Chemotherapy Compounding Immunization 
European Pharmaceutical Review
OCTOBER 25, 2024
The biologic ZL-1310 is being investigated in an ongoing Phase Ia/Ib study in these patients who have had at least one platinum-based chemotherapy regimen. The compound was designed to address issues such as payload toxicity seen in first-generation ADC therapies, according to Zai Lab.
European Pharmaceutical Review
OCTOBER 19, 2023
With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. How do you perceive radiopharmaceuticals complementing existing cancer treatments, such as chemotherapy and immunotherapy? What do you envision the future of radiopharmaceuticals to be like?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
MARCH 8, 2024
It suppresses the immune system response at high doses and can treat problems such as rheumatoid arthritis. Autoimmune conditions Autoimmune disorders (or inflammatory disorders) are diseases caused by the immune system. Typically, the immune system targets foreign organisms and other substances.
The Checkup by Singlecare
JUNE 20, 2023
A healthy gut biome is crucial to your immune system and regulates proper digestion, bowel movements, and other bodily functions. These compounds may trigger headaches and migraines in some people. People with compromised immune systems. RELATED: Probiotics 101 What are the side effects of probiotics?
pharmaphorum
NOVEMBER 29, 2022
Amplifying and reinvigorating persistent T cell immunity has become a much-needed path to enhance anti-tumor efficacy. By enabling strong CD8 T-cell infiltration in cold tumor tissues, NT-I7, a compound developed by NeoImmuneTech, is capable of promoting a microenvironment that contributes to clinical efficacy, when combined with a CPI.
Pharmaceutical Technology
AUGUST 12, 2022
Adoptive cell therapy (ACT) is a form of cancer treatment that involves the transfer of immune cells into a patient to help fight the disease, by eliminating cancer cells. By 2028, the market is expected to reach $25 billion, with a compound annual growth rate (CAGR) of 46.6%. billion in 2021 and is forecast to reach $2.4
The Checkup by Singlecare
JANUARY 10, 2024
This test helps healthcare professionals diagnose a variety of diseases, such as kidney disease, liver damage, and autoimmune disorders, and provides information about one’s immune function. g/dL and may be associated with infections, certain cancers, or immune disorders. It occurs when the immune system is activated.
Expert insights. Personalized for you.
96 
Let's personalize your content